Ai Nakagawa - Publications

Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 18, 2018

Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: October 26, 2017

Association between vitamin D deficiency and pre-existing resistance-associated hepatitis C virus NS5A variants.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: March 17, 2016

Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients.

Journal: World journal of gastroenterology

Published: February 23, 2016

Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study.

Journal: International journal of clinical oncology

Published: July 30, 2015

Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C.

Journal: Journal of medical virology

Published: April 17, 2015

Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C.

Journal: Internal medicine (Tokyo, Japan)

Published: March 07, 2015

Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients.

Journal: BMC infectious diseases

Published: January 17, 2015

Relationship between HCV dynamics and sustained virological responses in chronic hepatitis C genotype 1b patients treated with telaprevir-based triple therapy.

Journal: European journal of gastroenterology & hepatology

Published: October 31, 2014

Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C.

Journal: European journal of gastroenterology & hepatology

Published: April 16, 2014

Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: January 20, 2014

Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: October 11, 2013